# Jasper Therapeutics, Inc.: Form 8-K, filed Dec 3, 2020

- Company: [Jasper Therapeutics, Inc.](/companies/jspr.md) (CIK 1788028)
- Form: 8-K
- Filed: 2020-12-03
- Accepted by EDGAR: Dec 3, 2020, 12:08 ET
- Period: 2020-12-01
- Accession: 0001213900-20-040662
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1788028/000121390020040662/ea130727-8k_amplitudehealt.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1788028/000121390020040662/

## Items reported

- Item 5.08: Item not in the standard list
- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1788028/000121390020040662/ea130727-8k_amplitudehealt.htm

Filed Dec 3, 2020.
Source: SEC EDGAR, the filing index for accession 0001213900-20-040662. Last ingested by Listed: Nov 9, 2026, 17:50 ET. No prices; not investment advice.